Thesis sells personalized nootropic supplement stacks for consumers seeking improved focus, energy, memory, and mood. It operates a direct-to-consumer subscription model that uses online assessments and iterative testing to tailor formulas. Founded in 2017 and headquartered in New York, the company raised a Series A in 2023.